Parker “Pete” Petit has resigned as CEO and board chairman of MiMedx Group amid an investigation into the company’s accounting practices. Petit is staying on as a board member, the company said.
MiMedx has named as interim CEO David Coles, a managing director at turnaround firm Alvarez & Marsal.
Petit, whose company makes tissue treatments used to speed the healing of wounds, reduce scar tissue formation and reduce inflammation, was profiled by FierceCEO in December.
